1. |
Cao C, Manganas C, Bannon P, et al. Drug-eluting stents versus coronary artery bypass graft surgery In left main coronary artery disease:a meta-analysis of early outcomes from randomized and non-randomized studies. J Thorac Cardiovasc Surg, 2013, 145(3):738-747.
|
2. |
Hueb W, Soares PR, Gersh BJ, et al. The medicine, angioplasty,or surgery study (MASS-Ⅱ):a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease:one-year results. J Am Coll Cardiol, 2004, 43(10):1743-1751.
|
3. |
Rodriguez AE, Baldi J, Fernandez Pereira C, et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI Ⅱ). J Am Coll Cardiol, 2005, 46(4):582-588.
|
4. |
Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease:the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol, 2005, 46(4):575-581.
|
5. |
Booth J, Clayton T, Pepper J, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease:six-year follow-up from the Stent or Surgery Trial (SoS). Circulation, 2008, 118(4):381-388.
|
6. |
Navarese EP, Kubica J, Castriota F, et al. Safety and efficacy of biodegradable vs durable polymer drug-eluting stents:evidence from a meta-analysis of randomized trials. EuroIntervention, 2011, 7(8):985-994.
|
7. |
De Luca G, Dirksen MT, Spaulding C, et al. Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation. Drug-eluting vs bare-metal stents in primary angioplasty:a pooled patient-level meta-analysis of randomized trials. Arch Intern Med, 2012, 172(8):611-621.
|
8. |
Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents:a collaborative network meta-analysis. Lancet, 2007, 370(9591):937-948.
|
9. |
Carson JL, Scholz PM, Chen AY, et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol, 2002, 40(3):418-423.
|
10. |
Briguori C, Condorelli G, Airoldi F, et al. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol, 2007, 99(6):779-784.
|
11. |
Lee MS, Jamal F, Kedia G, et al. Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. Int J Cardiol, 2007, 123(1):34-42.
|
12. |
Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0).[cited 2012 Jan 5]. Available at:http://www.cochrane-handbook.org.
|
13. |
Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009, 360(10):961-972.
|
14. |
Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients.1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol, 2010, 55(5):432-440.
|
15. |
Boudriot E, Thiele H, Walther T, et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol, 2011, 57(5):538-545.
|
16. |
Park SJ, Kim YH, Park DW, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med, 2011, 364 (18):1718-1727.
|
17. |
Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med, 2012, 367(25):2375-2384.
|
18. |
Kamalesh M, Sharp TG, Tang XC, et al. Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes. J Am Coll Cardiol, 2013, 61(8):808-816.
|
19. |
Ahn JM, Roh JH, Kim YH, et al. Randomized trial of Stents versus bypass surgery for left main coronary artery disease 5-Year outcomes of the PRECOMBAT Study. J Am Coll Cardiol, 2015, 65(20):2198-2206.
|
20. |
Mack MJ, Osborne JA, Shennib H. Arterial graft patency in coronary artery bypass grafting:what do we really know? Ann Thorac Surg, 1998, 66 (3):1055-1059.
|
21. |
Newman MF, Kirchner JL, Phillips-Bute B, et al. Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary artery bypass surgery. N Engl J Med, 2001, 344(6):395-402.
|
22. |
Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative effectiveness of revascularization strategies. N Engl J Med, 2012, 366(16):1467-1476.
|
23. |
Kappetein AP, Head SJ, Morice MC, et al. Treatment of complex coronary artery disease in patients with diabetes:5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg, 2013, 43(5):1006-1013.
|